Skip to main content

Table 1 Activity of ABT-737, ABT-199 and WEHI-539 in ovarian cancer cell lines cell growth assays. Cells were treated with the indicated BH3 mimetic for 72 h and surviving cell number estimated by staining with SRB. The results are expressed as mean ± S.D. of the number of experiments shown in parentheses

From: Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells

IC50 (μM)

Cell line

ABT-737

ABT-199

WEHI-539

OVCAR-8

11 ± 5 (12)

18 ± 6 (13)

9 ± 5 (11)

OVCAR-3

10 ± 4 (11)

15 ± 5 (12)

9 ± 4 (14)

IGROV-1

11 ± 1 (12)

14 ± 8 (14)

16 ± 12 (12)

COV-362

17 ± 3 (10)

4 ± 2 (9)

12 ± 2 (9)

OVCAR-4

14 ± 5 (8)

15 ± 2 (7)

26 ± 9 (7)

OVSAHO

7 ± 1 (10)

17 ± 9 (6)

14 ± 1 (6)

COV-318

20 ± 3 (5)

24 ± 2 (3)

23 ± 5 (3)

FUOV-1

13 ± 1 (4)

14 ± 6 (3)

27 ± 4 (3)